ArticleFrontiers in pharmacology2020

Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries.

András Inotai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.